Lyme Disease Testing: How Diagnosis Works and When to Get Tested

Why Testing for Lyme Disease Is More Complicated Than It Looks

Lyme disease, caused by the bacterium Borrelia burgdorferi, is the most common tick-borne illness in the United States. Each year, tens of thousands of people are diagnosed, with the highest concentrations in the Northeast, upper Midwest, and parts of the Pacific Coast.

Despite how common it is, testing for Lyme disease trips up patients and providers alike. The tests available detect your immune response to the bacteria, not the bacteria themselves. That distinction has real consequences for when to test, how to interpret results, and what to do when the numbers and the clinical picture don't match.

The Two-Tier Testing Process

The standard approach to Lyme disease testing uses two sequential blood tests. This two-tier system is endorsed by the CDC and most major medical organizations.

Step One: The ELISA (or EIA) Screening Test

The first test is an enzyme-linked immunosorbent assay, commonly called an ELISA or EIA. It screens your blood for antibodies to Borrelia burgdorferi. The test is sensitive, meaning it catches most true infections, but it also generates false positives from other conditions like autoimmune diseases, certain viral infections, and even other tick-borne illnesses.

Because of this tendency toward false positives, a positive or equivocal ELISA alone is not enough to diagnose Lyme disease.

Step Two: The Western Blot Confirmation

Any positive or borderline ELISA result moves to a Western blot, which looks for specific antibody bands against multiple bacterial proteins. This test is more specific, meaning it filters out most false positives from the first round.

The Western blot reports results in two categories. IgM bands appear earlier in infection, typically within the first few weeks. IgG bands develop later and reflect more established immune response. A positive IgM with a negative IgG early in illness may indicate active infection. A positive IgG alone or with IgM at later stages strongly supports the diagnosis.

A result is only considered positive when enough specific bands are present, not just any reaction. This cutoff is defined by CDC criteria and is what distinguishes a true positive from background immune noise.

Why Timing Matters: The Antibody Development Window

This is where most testing confusion originates. After Borrelia burgdorferi enters your body, your immune system needs time to mount a detectable antibody response. That window is typically 2 to 4 weeks.

If you test during this early phase, your ELISA can return negative even when infection is present. This is called a false negative, and it is common in early Lyme disease. Testing the same person two to four weeks later often yields a positive result as antibodies reach detectable levels.

This is why the testing timeline cannot be separated from the clinical context. A negative test one week after a tick bite means almost nothing on its own.

When to Test vs. When to Treat Without Testing

Not every situation calls for testing first. The right approach depends heavily on what symptoms are present.

The Bullseye Rash: Treat First, Test Later

Erythema migrans, the expanding circular or oval rash that often (though not always) shows a central clearing, is the hallmark early sign of Lyme disease. It appears in roughly 70 to 80 percent of confirmed cases, typically developing 3 to 30 days after a bite.

When a patient presents with a classic erythema migrans rash and a history of tick exposure in an endemic area, treatment with antibiotics should begin immediately. Testing is not required to initiate therapy. The rash is diagnostic on its own, and waiting for lab confirmation delays treatment unnecessarily.

Non-Specific Symptoms After Tick Exposure: Test First

If you had a tick bite and develop flu-like symptoms (fever, fatigue, headaches, joint pain) without a visible rash, testing makes sense. These symptoms are common to many illnesses, so lab confirmation helps narrow the diagnosis.

In this scenario, the timing of the bite matters. Testing within the first week or two will likely return a false negative regardless of whether infection is present. Your provider may order tests and ask you to repeat them in two to four weeks, or start empirical treatment if symptoms are significant and exposure risk was high.

Late or Disseminated Symptoms: Testing Is More Reliable

Patients who present weeks to months after a potential exposure with joint swelling, neurological symptoms (facial palsy, numbness), or cardiac issues are more likely to have detectable antibodies. At this stage, two-tier testing is more reliable and a negative result carries more weight.

What Your Results Actually Mean

Positive ELISA, Positive Western Blot

This combination, meeting the CDC band criteria, is considered a positive Lyme disease test. Combined with compatible symptoms, it supports a diagnosis and a course of treatment.

Positive ELISA, Negative Western Blot

This is a common outcome. The Western blot filtering out the ELISA signal usually means a false positive from the ELISA, not Lyme disease. Other conditions may need investigation.

Negative ELISA

If the screen is negative, the Western blot is not run. A negative ELISA in a patient with a rash and recent tick exposure in an endemic area should be interpreted with caution if symptoms only started within the past two weeks. The antibody window may not have opened yet.

Equivocal Results

Some tests return a borderline result. These are typically retested, sometimes with a repeat draw in two to four weeks to see whether antibody levels rise as expected with active infection.

Limitations of Current Lyme Disease Tests

Understanding what these tests cannot do is as important as knowing what they can.

The tests detect antibodies, not the bacteria. They cannot tell whether Borrelia burgdorferi is still present and actively replicating. Once your immune system responds to infection, IgG antibodies can remain elevated for months or even years after treatment and full recovery. A positive test long after completed therapy does not mean the infection persists or that more antibiotics are needed.

False negatives are common in early infection, as described above. False positives occur with certain autoimmune conditions, other spirochete infections, and occasionally with viral illnesses. Neither outcome is rare.

The tests also do not directly measure disease severity or predict complications. Two people can have identical test results with very different clinical courses.

Newer and Investigational Tests

Researchers have worked to develop tests that detect Borrelia burgdorferi directly rather than relying on antibody response. PCR testing for bacterial DNA exists, but it has limited sensitivity in blood because the bacteria rarely circulates in detectable concentrations there. PCR on joint fluid in Lyme arthritis cases performs better and is used in that context. Additional antigen and metabolite-based assays are under study, but none have displaced the two-tier antibody method as the standard of care. The current Lyme disease lab tests available reflect this reality: antibody detection remains the backbone of diagnosis.

The "Lyme-Literate" Controversy

Some patients, particularly those with persistent symptoms, seek out practitioners who advertise themselves as "Lyme-literate" doctors. These providers sometimes use non-standard tests, including certain commercial labs that apply different interpretive criteria than the CDC-endorsed guidelines, or tests not approved by the FDA.

The CDC and most academic medical centers do not endorse these alternative testing methods. Studies have found high rates of false positives, leading patients to receive prolonged antibiotic courses for what may not be active Lyme infection. If you are experiencing ongoing symptoms after treatment, discuss them with your physician. Post-treatment Lyme disease syndrome is real, but extended antibiotic therapy has not been shown to help, and non-standard tests should be interpreted with caution.

What to Do If You Think You Have Lyme but Tests Are Negative

A negative test does not automatically close the door on a Lyme disease diagnosis.

If you have an erythema migrans rash, a clinical diagnosis is valid on its own, and treatment should proceed without waiting for positive serology. The rash is considered diagnostic.

If symptoms are non-specific and exposure history is clear, discuss timing with your provider. A second test in two to four weeks may turn positive if the first was drawn during the antibody development window.

If you have been treated and now have new symptoms weeks to months later, reinfection is possible and new symptoms should be assessed on their own merits.

The Bottom Line

Lyme disease testing works best when you understand what it can and cannot tell you. The two-tier blood test is reliable in the right clinical context but has real limitations in early infection. A negative result in the first two weeks means little. A classic rash means you should start treatment now, not later.

If you have been bitten by a tick, are unsure whether and when to test, or have received unclear results, Doctronic.ai connects you with a licensed clinician who can evaluate your full picture and guide you through the next steps.